566 related articles for article (PubMed ID: 20212113)
21. Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice.
Brachmann SM; Ueki K; Engelman JA; Kahn RC; Cantley LC
Mol Cell Biol; 2005 Mar; 25(5):1596-607. PubMed ID: 15713620
[TBL] [Abstract][Full Text] [Related]
22. Recruitment of the tyrosine phosphatase Src homology 2 domain tyrosine phosphatase-2 to the p85 subunit of phosphatidylinositol-3 (PI-3) kinase is required for insulin-like growth factor-I-dependent PI-3 kinase activation in smooth muscle cells.
Kwon M; Ling Y; Maile LA; Badley-Clark J; Clemmons DR
Endocrinology; 2006 Mar; 147(3):1458-65. PubMed ID: 16306077
[TBL] [Abstract][Full Text] [Related]
23. Targeting therapeutic liabilities engendered by PIK3R1 mutations for cancer treatment.
Cheung LW; Mills GB
Pharmacogenomics; 2016 Feb; 17(3):297-307. PubMed ID: 26807692
[TBL] [Abstract][Full Text] [Related]
24. Expression of a mutated form of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase in a Hodgkin's lymphoma-derived cell line (CO).
Jücker M; Südel K; Horn S; Sickel M; Wegner W; Fiedler W; Feldman RA
Leukemia; 2002 May; 16(5):894-901. PubMed ID: 11986952
[TBL] [Abstract][Full Text] [Related]
25. Class IA PI3K regulatory subunits: p110-independent roles and structures.
Fox M; Mott HR; Owen D
Biochem Soc Trans; 2020 Aug; 48(4):1397-1417. PubMed ID: 32677674
[TBL] [Abstract][Full Text] [Related]
26. The negative regulation of phosphoinositide 3-kinase signaling by p85 and it's implication in cancer.
Luo J; Cantley LC
Cell Cycle; 2005 Oct; 4(10):1309-12. PubMed ID: 16131837
[TBL] [Abstract][Full Text] [Related]
27. Direct association of p110 beta phosphatidylinositol 3-kinase with p85 is mediated by an N-terminal fragment of p110 beta.
Hu P; Schlessinger J
Mol Cell Biol; 1994 Apr; 14(4):2577-83. PubMed ID: 8139559
[TBL] [Abstract][Full Text] [Related]
28. In vivo functional analysis of the counterbalance of hyperactive phosphatidylinositol 3-kinase p110 catalytic oncoproteins by the tumor suppressor PTEN.
Andrés-Pons A; Rodríguez-Escudero I; Gil A; Blanco A; Vega A; Molina M; Pulido R; Cid VJ
Cancer Res; 2007 Oct; 67(20):9731-9. PubMed ID: 17942903
[TBL] [Abstract][Full Text] [Related]
29. Phosphatidylinositol-3 kinase p85 enhances expression from the myelin basic protein promoter in oligodendrocytes.
Clark RE; Miskimins WK; Miskimins R
J Neurochem; 2002 Nov; 83(3):565-73. PubMed ID: 12390518
[TBL] [Abstract][Full Text] [Related]
30. A PI3K activity-independent function of p85 regulatory subunit in control of mammalian cytokinesis.
García Z; Silio V; Marqués M; Cortés I; Kumar A; Hernandez C; Checa AI; Serrano A; Carrera AC
EMBO J; 2006 Oct; 25(20):4740-51. PubMed ID: 17024187
[TBL] [Abstract][Full Text] [Related]
31. The p85beta regulatory subunit of PI3K serves as a substrate for PTEN protein phosphatase activity during insulin mediated signaling.
He J; de la Monte S; Wands JR
Biochem Biophys Res Commun; 2010 Jul; 397(3):513-9. PubMed ID: 20515662
[TBL] [Abstract][Full Text] [Related]
32. The p85 regulatory subunit controls sequential activation of phosphoinositide 3-kinase by Tyr kinases and Ras.
Jimenez C; Hernandez C; Pimentel B; Carrera AC
J Biol Chem; 2002 Nov; 277(44):41556-62. PubMed ID: 12196526
[TBL] [Abstract][Full Text] [Related]
33. Multiple roles for the p85α isoform in the regulation and function of PI3K signalling and receptor trafficking.
Mellor P; Furber LA; Nyarko JN; Anderson DH
Biochem J; 2012 Jan; 441(1):23-37. PubMed ID: 22168437
[TBL] [Abstract][Full Text] [Related]
34. Synergistic activation of a family of phosphoinositide 3-kinase via G-protein coupled and tyrosine kinase-related receptors.
Katada T; Kurosu H; Okada T; Suzuki T; Tsujimoto N; Takasuga S; Kontani K; Hazeki O; Ui M
Chem Phys Lipids; 1999 Apr; 98(1-2):79-86. PubMed ID: 10358930
[TBL] [Abstract][Full Text] [Related]
35. Phosphatidylinositol 3-kinase p85 adaptor function in T-cells. Co-stimulation and regulation of cytokine transcription independent of associated p110.
Kang H; Schneider H; Rudd CE
J Biol Chem; 2002 Jan; 277(2):912-21. PubMed ID: 11679587
[TBL] [Abstract][Full Text] [Related]
36. The structure of the inter-SH2 domain of class IA phosphoinositide 3-kinase determined by site-directed spin labeling EPR and homology modeling.
Fu Z; Aronoff-Spencer E; Backer JM; Gerfen GJ
Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3275-80. PubMed ID: 12629217
[TBL] [Abstract][Full Text] [Related]
37. The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2alpha.
Turner SJ; Domin J; Waterfield MD; Ward SG; Westwick J
J Biol Chem; 1998 Oct; 273(40):25987-95. PubMed ID: 9748276
[TBL] [Abstract][Full Text] [Related]
38. The p85 and p110 subunits of phosphatidylinositol 3-kinase-alpha are substrates, in vitro, for a constitutively associated protein tyrosine kinase in platelets.
Geltz NR; Augustine JA
Blood; 1998 Feb; 91(3):930-9. PubMed ID: 9446654
[TBL] [Abstract][Full Text] [Related]
39. Acute ethanol exposure inhibits insulin signaling in the liver.
He J; de la Monte S; Wands JR
Hepatology; 2007 Dec; 46(6):1791-800. PubMed ID: 18027876
[TBL] [Abstract][Full Text] [Related]
40. Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival.
Ueki K; Fruman DA; Brachmann SM; Tseng YH; Cantley LC; Kahn CR
Mol Cell Biol; 2002 Feb; 22(3):965-77. PubMed ID: 11784871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
